Repo J P, Barner-Rasmussen I, Roine R P, Sintonen H, Tukiainen E J
Department of Plastic Surgery, University of Helsinki and Helsinki University Hospital, HUS, Helsinki, Finland.
Department of Plastic Surgery, University of Helsinki and Helsinki University Hospital, HUS, Helsinki, Finland.
J Plast Reconstr Aesthet Surg. 2016 Apr;69(4):524-32. doi: 10.1016/j.bjps.2015.12.011. Epub 2016 Jan 14.
Extensive compound tibial fractures present reconstructive challenges. The present study aimed to assess the outcomes of microvascular latissimus dorsi (LD) flap combined with the Ilizarov technique for extensive compound tibial fractures with bone loss and bone healing complications.
Patient records were reviewed retrospectively. The Lower Extremity Functional Scale (LEFS), the Disabilities of the Arm, Hand and Shoulder (DASH), and the 15D health-related quality of life (HRQoL) instrument were applied.
Between 1989 and 2014, 16 patients underwent reconstruction with a microvascular LD flap and bone transport (11/16) or late bone lengthening (5/16). The mean clinical follow-up time was 6.6 (standard deviation (SD): 6.5) years. Three patients had minor complications requiring reoperation. Partial necrosis of one flap required late flap reconstruction in one case. Late bone grafting was used to enhance union in eight of 16 cases. The mean new bone gain was 3.8 cm (SD: 2.5). Overall, 11 patients completed the questionnaires in a mean of 22.3 years (SD: 2.4) after surgery. The main findings revealed a relatively good function of the reconstructed limb and good shoulder function. The mean HRQoL was comparable to that of an age-standardized sample of the general population.
Segmental tibia transport and lengthening to correct limb length discrepancy do not compromise the microvascular muscle flap. Combined microvascular LD flap reconstruction and the Ilizarov technique can be used in treating acute compound tibial defects, pseudoarthrosis, and osteitis, all associated with significant amputation risk. Fair long-term functional outcomes and HRQoL are achieved when these combined techniques are used.
广泛的胫骨复合骨折带来了重建挑战。本研究旨在评估背阔肌(LD)微血管皮瓣联合伊利扎罗夫技术治疗伴有骨缺损和骨愈合并发症的广泛胫骨复合骨折的疗效。
对患者记录进行回顾性分析。应用下肢功能量表(LEFS)、手臂、手部和肩部功能障碍量表(DASH)以及15D健康相关生活质量(HRQoL)工具。
1989年至2014年期间,16例患者接受了背阔肌微血管皮瓣联合骨运输(11/16)或后期骨延长(5/16)的重建手术。平均临床随访时间为6.6年(标准差(SD):6.5年)。3例患者出现轻微并发症,需要再次手术。1例皮瓣部分坏死,需要后期进行皮瓣重建。16例中有8例采用后期植骨促进骨愈合。平均新骨生长量为3.8厘米(SD:2.5厘米)。总体而言,11例患者在术后平均22.3年(SD:2.4年)完成了问卷调查。主要结果显示,重建肢体功能相对良好,肩部功能良好。平均HRQoL与一般人群的年龄标准化样本相当。
胫骨节段性运输和延长以纠正肢体长度差异不会影响微血管肌皮瓣。背阔肌微血管皮瓣重建与伊利扎罗夫技术联合应用可用于治疗急性胫骨复合缺损、骨不连和骨髓炎,这些均伴有较高的截肢风险。采用这些联合技术可取得较好的长期功能结果和HRQoL。